BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34018168)

  • 1. Pre-and Post-Surgical Health-Related Quality of Life Evaluation of Spheno-orbital Meningioma Patients Based on EORTC QLQ-C30 Questionnaire at Dr. Cipto Mangunkusumo General Hospital.
    Aman RA; Wisyesa K; Nugroho AW; Ichwan S; Tandian D; Ashari S; Nugroh SW
    Acta Neurol Taiwan; 2020 Dec; 29(4)():99-102. PubMed ID: 34018168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life.
    Nassiri F; Price B; Shehab A; Au K; Cusimano MD; Jenkinson MD; Jungk C; Mansouri A; Santarius T; Suppiah S; Teng KX; Toor GS; Zadeh G; Walbert T; Drummond KJ;
    Neuro Oncol; 2019 Jan; 21(Suppl 1):i32-i43. PubMed ID: 30649488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
    de Ligt KM; Aaronson NK; Liegl G; Nolte S;
    Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life outcomes in incidental and operated meningiomas (QUALMS): a cross-sectional cohort study.
    Keshwara SM; Gillespie CS; Mustafa MA; George AM; Richardson GE; Clynch AL; Wang JZ; Lawson DDA; Gilkes CE; Farah JO; Yousaf J; Chavredakis E; Mills SJ; Brodbelt AR; Zadeh G; Millward CP; Islim AI; Jenkinson MD
    J Neurooncol; 2023 Jan; 161(2):317-327. PubMed ID: 36525165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normative data for the EORTC QLQ-C30 from the Austrian general population.
    Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
    Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term health-related quality of life and neurocognitive functioning after treatment in skull base meningioma patients.
    Fisher FL; Zamanipoor Najafabadi AH; van der Meer PB; Boele FW; Peerdeman SM; Peul WC; Taphoorn MJB; Dirven L; van Furth WR
    J Neurosurg; 2022 Apr; 136(4):1077-1089. PubMed ID: 34598137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    Sibhat SG; Fenta TG; Sander B; Gebretekle GB
    Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30): validation of English version in Singapore.
    Luo N; Fones CS; Lim SE; Xie F; Thumboo J; Li SC
    Qual Life Res; 2005 May; 14(4):1181-6. PubMed ID: 16041912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
    Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
    Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
    Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after resection of a meningioma-A cross-cultural comparison of Indian and Australian patients.
    Schadewaldt V; Cherkil S; Panikar D; Drummond KJ
    PLoS One; 2022; 17(9):e0275184. PubMed ID: 36155666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
    Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
    Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
    Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
    Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.